Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Lipid Luminations

Statin Safety Considerations

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University.

     

    Brought to you by:

    NLA logo

     

Recommended
Details
Presenters
Comments
  • Overview

    Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University.

     

    Brought to you by:

    NLA logo

     

Schedule15 Nov 2024